The Global EEG/EMG Equipment market has also been witnessing the trend of novel molecules, launched to treat central nervous system disorders effectively. However, patent expiration of key drugs could pose a challenge to the growth of this market, the Global Central Nervous System Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Central Nervous System Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Authored by: TechNavio
Published: July 2012
Format: Electronic - PDF by eMail
Number of Pages: #56
Table of Contents
1. Executive Summary
2. Introduction
3. Market Coverage
4. Market Landscape
4.1 Global Antipsychotics Market
4.2 Global Antidepressants Market
4.3 Global Antiepileptic Drugs Market
4.4 Global Anti-Alzheimer's Drugs Market
4.5 Global ADHD Drugs Market
4.6 Global Hypnotics Market
4.7 Global Anti-Parkinson's Drugs Market
4.8 Global Antimigraine Drugs Market
5. Geographical Segmentation
6. Key Leading Countries
7. Rate of Incidence and Prevalence
8. Vendor Landscape
8.1 Global Antipsychotics Market Segment
8.2 Global Antidepressants Market Segment
8.3 Global Antiepileptic Drugs Market Segment
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Eli Lilly and Co.
15.2 Pfizer Inc.
15.3 AstraZeneca plc
15.4 Johnson and Johnson Ltd.
16. Other Reports in this Series
List of Exhibits
1. Global Central Nervous System Drugs Market 2011–2015 (US$ billion)
2. Global Central Nervous System Drugs Market Segmentation 2011
3. Global Central Nervous System Drugs Market by Product Segmentation 2011–2015 (percent)
4. Global Antipsychotics Market 2011–2015 (US$ billion)
5. Global Antidepressants Market 2011–2015 (US$ billion)
6. Global Antiepileptic Drugs Market 2011–2015 (US$ billion)
7. Global Anti-Alzheimer's Drugs Market 2011–2015 (US$ billion)
8. Global Attention Deficit Hyperactivity Disorder Drugs Market 2011–2015 (US$ billion)
9. Global Hypnotics Market 2011–2015 (US$ billion)
10. Global Anti-Parkinson's Drugs Market 2011–2015 (US$ billion)
11. Global Antimigraine Drugs Market 2011–2015 (US$ billion)
12. Global Central Nervous System Market by Overall Market Segmentation (US$ billion)
13. Global Central Nervous System Drugs Market by Geographi
Companies Mentioned
1. AstraZeneca plc
2. Eli Lilly & Co.
3. Johnson & Johnson
4. Pfizer